We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CRBU market cap is 132.21M. The company's latest EPS is USD -1.1272 and P/E is -1.27.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 23.66M | 3.56M | 2.43M | 3.46M | 2.02M |
| Operating Income | -14.63M | -37.45M | -46M | -43.5M | -38.74M |
| Net Income | -10M | -34.51M | -41.23M | -37.7M | -34.68M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.6M | 13.85M | 34.48M |
| Operating Income | -66.98M | -106.4M | -116.07M |
| Net Income | -66.92M | -99.42M | -102.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 457.52M | 432.21M | 406.83M | 372.94M | 344.33M |
| Total Liabilities | 59.25M | 63.81M | 63.54M | 62.47M | 63.13M |
| Total Equity | 398.27M | 368.4M | 343.29M | 310.46M | 281.2M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 442.36M | 373.77M | 432.21M |
| Total Liabilities | 54.53M | 72.89M | 63.81M |
| Total Equity | 387.83M | 300.87M | 368.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -71.91M | -93.29M | -37.2M | -70.07M | -102.73M |
| Investing | -36.71M | -68.18M | 22.96M | 44.16M | 70.68M |
| Financing | 154.34M | 154.3M | 12.49M | 12.62M | 12.86M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.52M | -90.97M | -93.29M |
| Investing | -176.4M | -93.25M | -68.18M |
| Financing | 433.43M | 2.13M | 154.3M |
| Market Cap | 132.21M |
| Price to Earnings Ratio | -1.27 |
| Price to Sales Ratio | 3.76 |
| Price to Cash Ratio | 2.53 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 90.55M |
| Average Volume (1 week) | 1.57M |
| Average Volume (1 Month) | 1.56M |
| 52 Week Change | -75.67% |
| 52 Week High | 8.33 |
| 52 Week Low | 1.30 |
| Spread (Intraday) | 0.04 (2.68%) |
| Company Name | Caribou Biosciences Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.cariboubio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
